Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
View ORCID ProfileNicolás A. Muena, View ORCID ProfileTamara García-Salum, View ORCID ProfileCatalina Pardo-Roa, View ORCID ProfileEileen F. Serrano, View ORCID ProfileJorge Levican, María José Avendaño, View ORCID ProfileLeonardo I. Almonacid, View ORCID ProfileGonzalo Valenzuela, Estefany Poblete, Shirin Strohmeier, Erick Salinas, View ORCID ProfileDenise Haslwanter, View ORCID ProfileMaria Eugenia Dieterle, View ORCID ProfileRohit K. Jangra, View ORCID ProfileKartik Chandran, View ORCID ProfileClaudia González, View ORCID ProfileArnoldo Riquelme, View ORCID ProfileFlorian Krammer, View ORCID ProfileNicole D. Tischler, View ORCID ProfileRafael A. Medina
doi: https://doi.org/10.1101/2021.05.17.21257197
Nicolás A. Muena
1Laboratorio de Virología Molecular, Fundación Ciencia & Vida, Av. Zañartu 1482, Santiago, Chile
Ph.D.Tamara García-Salum
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Ph.D.Catalina Pardo-Roa
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
D.V.M., Ph.D.Eileen F. Serrano
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
4PhD Program in Biological Sciences, Mention in Molecular Genetics and Microbiology, Faculty of Biological Science, Pontificia Universidad Católica de Chile, Santiago, Chile
Ph.D.(c)Jorge Levican
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Ph.D.María José Avendaño
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
4PhD Program in Biological Sciences, Mention in Molecular Genetics and Microbiology, Faculty of Biological Science, Pontificia Universidad Católica de Chile, Santiago, Chile
Ph.D.(c)Leonardo I. Almonacid
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Ph.D.Gonzalo Valenzuela
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
M.D.Estefany Poblete
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
B.T.Shirin Strohmeier
5Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Ph.D.Erick Salinas
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
R.N.Denise Haslwanter
6Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA
Ph.D.Maria Eugenia Dieterle
6Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA
Ph.D.Rohit K. Jangra
6Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA
Ph.D.Kartik Chandran
6Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA
Ph.D.Claudia González
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
7Department of Otorhinolaryngology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
M.D.Arnoldo Riquelme
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
8Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
9Department of Health Sciences, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
M.D.Florian Krammer
5Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
10Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Ph.D.Nicole D. Tischler
1Laboratorio de Virología Molecular, Fundación Ciencia & Vida, Av. Zañartu 1482, Santiago, Chile
11Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile
Ph.D.Rafael A. Medina
2Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
3Advanced Interdisciplinary Rehabilitation Register (AIRR) – COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
5Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Ph.D.
Article usage
Posted May 18, 2021.
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
Nicolás A. Muena, Tamara García-Salum, Catalina Pardo-Roa, Eileen F. Serrano, Jorge Levican, María José Avendaño, Leonardo I. Almonacid, Gonzalo Valenzuela, Estefany Poblete, Shirin Strohmeier, Erick Salinas, Denise Haslwanter, Maria Eugenia Dieterle, Rohit K. Jangra, Kartik Chandran, Claudia González, Arnoldo Riquelme, Florian Krammer, Nicole D. Tischler, Rafael A. Medina
medRxiv 2021.05.17.21257197; doi: https://doi.org/10.1101/2021.05.17.21257197
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
Nicolás A. Muena, Tamara García-Salum, Catalina Pardo-Roa, Eileen F. Serrano, Jorge Levican, María José Avendaño, Leonardo I. Almonacid, Gonzalo Valenzuela, Estefany Poblete, Shirin Strohmeier, Erick Salinas, Denise Haslwanter, Maria Eugenia Dieterle, Rohit K. Jangra, Kartik Chandran, Claudia González, Arnoldo Riquelme, Florian Krammer, Nicole D. Tischler, Rafael A. Medina
medRxiv 2021.05.17.21257197; doi: https://doi.org/10.1101/2021.05.17.21257197
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12630)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (411)
- Health Economics (717)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2230)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)